Vimarsana
Biggest News Aggregation in the World

Subra Sankar News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Subra Sankar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Subra Sankar Today - Breaking & Trending Today

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q3 2023 Earnings Call Transcript - Vimarsana News

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q3 2023 Earnings Call Transcript

Operator: Thank you for standing by, and welcome to the Nautilus Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.

Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell Development - Vimarsana News

Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell Development

Former Quantapore founder and CEO brings 20 years of proteomics and genomics industry experience to company developing a platform for comprehensively quantifying the proteomeSEATTLE, Nov. 01, 2023 ...

Nautilus Biotechnology Appoints Martin Huber, Ph.D., as - Vimarsana News

Nautilus Biotechnology Appoints Martin Huber, Ph.D., as

Former Quantapore founder and CEO brings 20 years of proteomics and genomics industry experience to company developing a platform for comprehensively...

Sujal Patel-led Nautilus Biotechnology goes public as it tackles ambitious plan to analyze proteins - Vimarsana News

Sujal Patel-led Nautilus Biotechnology goes public as it tackles ambitious plan to analyze proteins

Nautilus Biotechnology is emerging as Seattle’s newest publicly traded company this week, taking advantage of the mania over SPACs to raise $345 million to fuel a new approach that could accelerate biomedical research and transform drug development.

Source: msn.com